Interview with Reinerio A. Deza, M.D., Head Global Pharmacovigilance at Cubist Pharmaceuticals, Inc
Join Industry Leading Professionals at the marcus evans 2nd Global Pharmacovigilance & Adverse Event Reporting ConferenceReinerio A. Deza answered a series of questions written by marcus evans before the forthcoming 2nd Global Pharmacovigilance & Adverse Event Reporting Conference , May 22-24, 2012 in Boston, MA. All responses represent the view of Mr. Deza and not necessarily those of Cubist Pharmaceuticals, Inc. Many pharmaceutical companies are facing budget cuts and also increased expectations to have a robust drug safety function. How does